1-5 of 5
Xuesong Liu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B191: Preclinical assessment of targeting the PI3K/AKT pathway in combination with other signal transduction pathway inhibitors

Sang Hyun Lee, Holly Koblish, Xiangdong Liu, Haifen Ye, Jun Li, Xuesong Liu, Melody Diamond, Yue Zhang, Leslie Hall, Valerie Dostalik, Margaret Favata, Elham Behshad, Richard Wynn, Yun-long Li, Andrew Combs, Chu-Bio Xue, Wenqing Yao, Gregory Hollis, Reid Huber, Peggy Scherle
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): B191.
DOI: https://doi.org/10.1158/1535-7163.TARG-15-B191
Published: 01 December 2015
View article
Journal Articles

Abstract B62: Potent single agent in vivo activity of the PARP inhibitor veliparib (ABT-888) in BRCA-deficient xenografts (MX-1 and Capan-1).

Cherrie K. Donawho, Luis E. Rodriguez, Paul A. Ellis, Lance Kaleta, Gail Bukofzer, Velitchka Bontcheva-Diaz, Xuesong Liu, Jennifer Bouska, Robert Carr, Kenneth Idler, Guidong Zhu, Thomas Penning, Alexander Shoemaker, Vincent L. Giranda, Fritz Buchanan, David J. Frost, Joann P. Palma
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): B62.
DOI: https://doi.org/10.1158/1535-7163.TARG-11-B62
Published: 12 November 2011
View article
Journal Articles

Abstract A161: Acquired resistance to combination treatment with TMZ and ABT‐888 is mediated by both BER and HR DNA repair pathways

Xuesong Liu, Edward K. Han, Mark G. Anderson, Yan Shi, Dimitri Semizarov, Gang Wang, Thomas McGonigal, Lisa Roberts, Ioren Iasko, Joann Palma, Gui‐Dong Zhu, Thomas Penning, Saul Rosenberg, Vincent Giranda, Yan Luo, Joel Leverson, Eric F. Johnson, Alexander R. Shoemaker
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): A161.
DOI: https://doi.org/10.1158/1535-7163.TARG-09-A161
Published: 10 December 2009
View article
Journal Articles

Inhibition of the phosphatidylinositol 3-kinase/Akt pathway sensitizes MDA-MB468 human breast cancer cells to cerulenin-induced apoptosis

Xuesong Liu, Yan Shi, Vincent L. Giranda, Yan Luo
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (3): 494–501.
DOI: https://doi.org/10.1158/1535-7163.MCT-05-0049
Published: 16 March 2006
View article
PDF
Journal Articles

Potent and selective inhibitors of Akt kinases slow the progress of tumors in vivo

Yan Luo, Alexander R. Shoemaker, Xuesong Liu, Keith W. Woods, Sheela A. Thomas, Ron de Jong, Edward K. Han, Tongmei Li, Vincent S. Stoll, Jessica A. Powlas, Anatol Oleksijew, Michael J. Mitten, Yan Shi, Ran Guan, Thomas P. McGonigal, Vered Klinghofer, Eric F. Johnson, Joel D. Leverson, Jennifer J. Bouska, Mulugeta Mamo, Richard A. Smith, Emily E. Gramling-Evans, Bradley A. Zinker, Amanda K. Mika, Phong T. Nguyen, Tilman Oltersdorf, Saul H. Rosenberg, Qun Li, Vincent L. Giranda
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2005) 4 (6): 977–986.
DOI: https://doi.org/10.1158/1535-7163.MCT-05-0005
Published: 14 June 2005
View article
PDF